Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Ocular Oncology
•
Ophthalmology
•
Pediatric Oncology
In which settings would you use external beam radiotherapy for retinoblastoma in the upfront (new diagnosis) setting?
Should it be used only for advanced cases as per ARET0321 or are other indications relevant?
Related Questions
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
Would you offer adjuvant radiation therapy in a young adult with NF1 who has a craniopharyngioma s/p STR?
What is the optimal salvage therapy for a patient with a relapsed primary mediastinal yolk sac tumor with brain metastases?
When should amblyopia treatment be initiated in patients being treated for retinoblastoma?
In a patients with bilateral Wilms' tumor with favorable features (>90% response to VAD, no anaplasia), what histopathologic criteria should be used to define a positive margin requiring focal RT to a partial nephrectomy bed?
How do you decide on treatment modality for ocular surface squamous neoplasia?
How do you differentiate demoralization from depression during cancer treatment?
For patients with Stage IIIB or IV HD flowing Bv-AVEPC with initial large mediastinal adenopathy, how can we avoid ISRT?